Leyuan Ma

Title: Leyuan Ma: Innovator in Chimeric Antigen Receptor Technology

Introduction

Leyuan Ma is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of immunotherapy, particularly in the development of chimeric antigen receptor (CAR) T cell technology. His innovative work has the potential to advance cancer treatment methodologies.

Latest Patents

Leyuan Ma holds 1 patent titled "Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs." This patent features chimeric antigen receptor (CAR) ligands, methods for their production, and immunomodulatory compositions that utilize these CAR ligands. The disclosure also includes methods for stimulating the activation of CAR-expressing cells, showcasing the potential for enhanced therapeutic applications.

Career Highlights

Leyuan Ma is affiliated with the Massachusetts Institute of Technology, where he continues to push the boundaries of research in immunotherapy. His work is characterized by a commitment to innovation and a focus on practical applications that can improve patient outcomes.

Collaborations

Leyuan Ma has collaborated with notable colleagues, including Darrell J. Irvine and Karl Dane Wittrup. These partnerships have fostered a collaborative environment that enhances the research and development of cutting-edge technologies in the field.

Conclusion

Leyuan Ma's contributions to CAR T cell technology exemplify the impact of innovative research in the medical field. His work not only advances scientific understanding but also holds promise for future therapeutic breakthroughs.